ELAVL1 and breast cancer: miR-519c reduced HIF-1α levels, suppressing tumor formation and angiogenesis in lung and breast cancer cell lines, while it also inhibited the biosynthesis of HuR, which regulates numerous cancer traits, including angiogenesis [27,29,30,70,71,79,80].